Student Health Insurance Plans Exclude or Severely Limit Psychiatric Medication Coverage

Many Student Health Insurance Plans (SHIPs) offered by universities provide mental health benefits on paper but exclude or place heavy restrictions on psychiatric medications. Common exclusions include brand-name SSRIs and SNRIs when generics exist, ADHD medications like Adderall and Vyvanse, newer medications like esketamine for treatment-resistant depression, and any medication prescribed off-label. Prior authorization requirements can take weeks, during which the student goes without medication. This matters because medication is not optional for many students. A student with moderate-to-severe depression who responds to a specific SSRI cannot simply switch to whatever generic the formulary covers without risking destabilization. A student with ADHD who has been stable on Vyvanse for years may find that their SHIP only covers immediate-release generic amphetamine salts, which has a different side effect profile and duration. The bureaucratic burden of fighting prior authorizations falls on students who are already struggling to function, and campus health centers are often understaffed to handle the volume of authorization requests. This persists because SHIPs are designed to be cheap enough for mandatory enrollment to be politically feasible. The average SHIP premium is $2,000-$3,000 per year, far below a standard individual market plan, and insurers achieve this by restricting formularies and imposing high out-of-pocket costs for specialty medications. Universities negotiate these plans prioritizing premium cost over coverage depth because they know that healthy 18-to-25-year-olds subsidize the pool. State insurance regulations often exempt SHIPs from the mental health parity requirements that apply to employer-sponsored plans, creating a regulatory gap that insurers exploit.